14. INT - Myths about chronic kidney disease in dogs

Chronic kidney disease (CKD) is thought to affect 0.5–1% of the dog population. However, it
seems that this prevalence is only a rough calculation and the number of dogs at risk of
developing CKD is probably higher.
An early diagnosis is essential because there is no cure for CKD; the clinical objective is to
reduce its progression. The most used diagnostic marker is creatinine level, but unfortunately,
it has many limitations. SDMA is a much more sensitive biomarker of glomerular filtration and
adds additional information when used in conjunction with creatinine. The detection of
proteinuria is also important for an early diagnosis. A urinalysis, therefore, is crucial in the
diagnosis of CKD, and simple urine test strips are ideal for screening purposes.
The treatment of CKD should always be tailored to each individual dog. In IRIS stages 1 and 2,
the vet should focus on reducing its progression, while the clinical signs should also be treated
in IRIS 3. By IRIS 4, however, it is time to start focusing on improving the patient’s quality of
life.
This webinar addresses 10 FAQs that every vet asks when treating dogs with chronic kidney
disease.

�� To receive the presentation of this webinar and the assistance certificate, please click on
the following link: https://docs.google.com/forms/d/1Q3Ep...
u9OTGi5W_ucjxlg/edit
If your question has not been answered during the conference, you can send it to the
following email address: [email protected]
Many thanks for joining us, and remember you have more information in our blog:
https://www.affinity-petcare.com/vets...